CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: July 24, 2006
Result type: Reports
Project Number: SR0074-000
Product Line: Reimbursement Review

Generic Name: Ciclesonide

Brand Name: Alvesco

Manufacturer: Altana Pharma Inc.

Therapeutic Area: asthma

Indications: asthma

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 20, 2006

Recommendation Type: List